Skip to main content

Table 1 Patient characteristics

From: CXCL12 expression promotes esophageal squamous cell carcinoma proliferation and worsens the prognosis

 

Patients (n = 79)

Age (median, range)

59 (44–79)

Gender (male/female)

71/8

Histological grade (1/2/3)

16/57/6

Depth of tumor invasion (Tis/T1/T2/T3)

10/35/7/27

Lymph node metastases (+)

46 (58 %)

Lymphatic invasion (+)

58 (73 %)

Vessel invasion (+)

35 (44 %)

Adjuvant therapy (none/chemotherapy/chemoradiotherapy)

62/16/1

Initial recurrence after surgery (none/lymph node/distant organ/both lymph node and distant organ)

45/14/10/10